December 3, 2024
Course running January – November 2024
Six modules
Online | Free
More information – Ecraid
Adaptive trial designs offer a compelling alternative where trial parameters can be modified during the trial, based on pre-specified rules, to respond to emerging research findings.
The European Clinical Research Alliance on Infectious Diseases (Ecraid) has embraced adaptive trial designs as a tool for facilitating faster, more efficient, and higher-quality clinical research. The ground-breaking trials REMAP-CAP and RECOVERY both achieved unmatched speed and efficiency thanks to their adaptive platform design.
- Module 1: General introduction to Ecraid and adaptive trial designs – available 31.01.2024
- Module 2: Seamless trial designs & endpoint selection – available 29.03.2024
- Module 3: Group sequential designs and sample size re-estimation – available on 31.05.2024
- Module 4: Response adaptive randomisation and covariate-adjusted response adaptive randomisation designs – available 31.07.2024
- Module 5: Platform trials and the personalised randomised controlled trial – available on 30.09.2024
- Module 6: Ethical and logistical concerns for adaptive designs, and CME test – available on 29.11.2024
ERS is one of 19 partners in the European Clinical Research Alliance on Infectious Diseases (Ecraid) consortium. Ecraid has launched a new educational series, the Ecraid training modules on adaptive clinical trial designs.